Canadian health officials are continuing to investigate a spike in anaphylaxis associated with one batch of the country's H1N1 vaccine, made by GlaxoSmithKline.
Canada Probes H1N1 Vaccine Anaphylaxis SpikeCourtesy MedPage Today Infectious Disease Mon, 11/30/2009 - 15:48
Canadian health officials are continuing to investigate a spike in anaphylaxis associated with one batch of the country's H1N1 vaccine, made by GlaxoSmithKline. More related itemsCanada Too Slow Starting H1N1 Vaccine Program,...
CDC: Young adults down 9 drinks when they binge
Brazil to ban sales of French-made breast implants
|
Popular by tags WeekMonth |
Post new comment